ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 183 filers reported holding ALKERMES PLC in Q3 2020. The put-call ratio across all filers is 9.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,787,525 | -5.9% | 2,312,976 | +5.2% | 0.02% | -4.5% |
| Q2 2023 | $68,822,420 | +12.7% | 2,198,787 | +1.5% | 0.02% | +4.8% |
| Q1 2023 | $61,055,395 | +108671.1% | 2,165,922 | +0.8% | 0.02% | +23.5% |
| Q4 2022 | $56,132 | -99.9% | 2,148,210 | +3.8% | 0.02% | -5.6% |
| Q3 2022 | $46,226,000 | -26.6% | 2,070,078 | -2.1% | 0.02% | -21.7% |
| Q2 2022 | $62,984,000 | +12.0% | 2,114,231 | -1.1% | 0.02% | +35.3% |
| Q1 2022 | $56,241,000 | +10.7% | 2,137,564 | -2.2% | 0.02% | +13.3% |
| Q4 2021 | $50,819,000 | -20.5% | 2,184,796 | +5.4% | 0.02% | -28.6% |
| Q3 2021 | $63,924,000 | +46.3% | 2,072,719 | +16.3% | 0.02% | +50.0% |
| Q2 2021 | $43,695,000 | +80.6% | 1,782,082 | +37.5% | 0.01% | +75.0% |
| Q1 2021 | $24,192,000 | +33.8% | 1,296,453 | +43.1% | 0.01% | +14.3% |
| Q4 2020 | $18,077,000 | +22.4% | 905,900 | +1.6% | 0.01% | +16.7% |
| Q3 2020 | $14,767,000 | -4.1% | 891,229 | +12.2% | 0.01% | -14.3% |
| Q2 2020 | $15,406,000 | +46.4% | 793,973 | +8.8% | 0.01% | +40.0% |
| Q1 2020 | $10,523,000 | -13.3% | 729,770 | +22.6% | 0.01% | +25.0% |
| Q4 2019 | $12,140,000 | +13.8% | 595,163 | +8.8% | 0.00% | 0.0% |
| Q3 2019 | $10,672,000 | +3.3% | 546,943 | +19.3% | 0.00% | 0.0% |
| Q2 2019 | $10,331,000 | -36.9% | 458,421 | +2.1% | 0.00% | -42.9% |
| Q1 2019 | $16,380,000 | +53.6% | 448,996 | +24.2% | 0.01% | +40.0% |
| Q4 2018 | $10,664,000 | +10.1% | 361,457 | +58.4% | 0.01% | +25.0% |
| Q3 2018 | $9,688,000 | +8.7% | 228,224 | +5.4% | 0.00% | 0.0% |
| Q2 2018 | $8,913,000 | -27.6% | 216,557 | +2.0% | 0.00% | -20.0% |
| Q1 2018 | $12,303,000 | +11.7% | 212,275 | +5.5% | 0.01% | 0.0% |
| Q4 2017 | $11,013,000 | +9.3% | 201,184 | +1.5% | 0.01% | +25.0% |
| Q3 2017 | $10,076,000 | -11.4% | 198,135 | +1.0% | 0.00% | -20.0% |
| Q2 2017 | $11,369,000 | -0.1% | 196,108 | +0.8% | 0.01% | 0.0% |
| Q1 2017 | $11,381,000 | +6.9% | 194,531 | +1.5% | 0.01% | 0.0% |
| Q4 2016 | $10,651,000 | +23.2% | 191,640 | +4.2% | 0.01% | 0.0% |
| Q3 2016 | $8,646,000 | +18.2% | 183,843 | +8.6% | 0.01% | +25.0% |
| Q2 2016 | $7,316,000 | +21.7% | 169,266 | -3.8% | 0.00% | 0.0% |
| Q1 2016 | $6,013,000 | -53.1% | 175,964 | +9.0% | 0.00% | -50.0% |
| Q4 2015 | $12,813,000 | +37.9% | 161,429 | +1.9% | 0.01% | +33.3% |
| Q3 2015 | $9,289,000 | -22.1% | 158,413 | -14.5% | 0.01% | -14.3% |
| Q2 2015 | $11,924,000 | -18.7% | 185,354 | -22.9% | 0.01% | -22.2% |
| Q1 2015 | $14,662,000 | -8.8% | 240,459 | -12.4% | 0.01% | -18.2% |
| Q4 2014 | $16,079,000 | +6.5% | 274,582 | -22.0% | 0.01% | 0.0% |
| Q3 2014 | $15,102,000 | -27.9% | 352,232 | -15.4% | 0.01% | -26.7% |
| Q2 2014 | $20,960,000 | +13.8% | 416,422 | -0.3% | 0.02% | +7.1% |
| Q1 2014 | $18,421,000 | -14.5% | 417,858 | -21.1% | 0.01% | -17.6% |
| Q4 2013 | $21,542,000 | -4.8% | 529,819 | -21.3% | 0.02% | -15.0% |
| Q3 2013 | $22,640,000 | +15.3% | 673,434 | -1.6% | 0.02% | +11.1% |
| Q2 2013 | $19,629,000 | – | 684,382 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |